Not recruitingISRCTN33930984

Does the identification and treatment of comorbid anxiety disorders in children with attention deficit hyperactivity disorder (ADHD) improve outcomes?

Research studyAges 8–12Australia

The study in practice

Understand this study

Listed age limits: 8 years to 12 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Murdoch Childrens Research Institute (Australia)
Sponsor type: Research institute
Study type: Other
Intervention type: Other / unclear
Study phase: Not clearly listed
Locations: Australia
Age range: From 8 Years to 12 Years
Official registry ID: ISRCTN33930984
Official title: Show the full official title
Does the identification and treatment of comorbid anxiety disorders in children with attention deficit hyperactivity disorder (ADHD) improve outcomes?

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: ISRCTN33930984. We help you review the study, but cannot decide medical eligibility.

Not recruiting

Australia

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Murdoch Childrens Research Institute (Australia), a research institute.

Who can participate?

Listed age limits: 8 years to 12 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.